Targeting Complement C3a Receptor to Improve Outcome After Ischemic Brain Injury
Targeting Complement C3a Receptor to Improve Outcome After Ischemic Brain Injury
About this item
Full title
Author / Creator
Publisher
New York: Springer US
Journal title
Language
English
Formats
Publication information
Publisher
New York: Springer US
Subjects
More information
Scope and Contents
Contents
Ischemic stroke is a major cause of disability. No efficient therapy is currently available, except for the removal of the occluding blood clot during the first hours after symptom onset. Loss of function after stroke is due to cell death in the infarcted tissue, cell dysfunction in the peri-infarct region, as well as dysfunction and neurodegenerat...
Alternative Titles
Full title
Targeting Complement C3a Receptor to Improve Outcome After Ischemic Brain Injury
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_swepub_primary_oai_gup_ub_gu_se_309131
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_gup_ub_gu_se_309131
Other Identifiers
ISSN
0364-3190,1573-6903
E-ISSN
1573-6903
DOI
10.1007/s11064-021-03419-6
